Fujifilm to highlight enterprise imaging, AI at SIIM 2018

Michael Walter | | Radiology Business | Enterprise Imaging

Fujifilm Medical Systems U.S.A. announced Wednesday, May 30, that it will be exhibiting its full enterprise imaging portfolio—including Synapse 5 PACS, Synapse 3D and Synapse VNA—and highlighting a new brand, REiLI, at the SIIM 2018 Annual Meeting May 31-June 2 in National Harbor, Maryland. REiLI represents the company’s medical informatics and artificial intelligence (AI) initiative.

“The theme of this year’s SIIM, ‘inspiring collaboration,’ is also the fuel powering REiLI,” said Bill Lacy, vice president of medical informatics at FUJIFILM Medical Systems U.S.A., in a prepared statement. “Through REiLI, we draw on insights from our strategic customers in the U.S. market to ensure our AI platform development, and our AI-enabled informatics applications, will deliver the most impactful and meaningful use cases for enterprise imaging.”

Attendees will also be invited to take part in a hands-on demo of many of the company’s solutions. Fujifilm Medical Systems U.S.A. will be located at booth #507 during the conference. More information is available on the company’s SIIM-focused website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

PHOTO GALLERY: Medical imaging technology at RSNA 2024
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Radiology vendor Visage Imaging scores $210M deal with large hospital system

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.